A Randomized Trial of Bictegravir or Dolutegravir with Emtricitabine and Tenofovir Alafenamide (F/TAF) Followed by Open Label Switch to Bictegravir/F/TAF Fixed Dose Combination
Sax, Paul E, Dejesus, Edwin, Crofoot, Gordon, Ward, Douglas, Benson, Paul, Wei, Lilian, White, Kirsten, Collins, Sean, Martin, Hal, Cheng, Andrew, Quirk, ErinVolume:
4
Language:
english
Journal:
Open Forum Infectious Diseases
DOI:
10.1093/ofid/ofx163.1076
Date:
October, 2017
File:
PDF, 165 KB
english, 2017